The RNA analytics market is expected to reach $8.8 billion by 2025 from $4.5 billion in 2020 with a CAGR of 13% over the forecast period. The growth of this market was primarily driven by growing demand for customized pharmaceuticals, increased pharmaceutical and biotech R&D expenditures and government funding for omics, and increased application of RNA sequencing in the transcriptome market.
A full report of RNA Analysis/Transcriptomics Market available at https://www.orionmarketreports.com/rna-analysis-transcriptomics-market/51382/
Global RNA Analysis/Transcriptomics Market Scope and Market Size
By Product
• Reagents/Consumables
• Instruments
• Software
• Services
By Technology
• Microarrays
• Sequencing
• Polymerase Chain Reaction
• RNA Interference
By Application
• Clinical Diagnostics
• Drug Discovery
• Toxicogenomics
• Comparative Transcriptomics
By End User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals
• Contract Research Organizations
Top Key Players in RNA Analysis/Transcriptomics Market Report are
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• GE Healthcare
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies Inc.
• Thermofisher Scientific Inc.
• Sigma Aldrich
• Qiagen N.V.
• Affymetrix Inc.
• Fluidigm Corporation
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
